9th July, 2014
FOR IMMEDIATE RELEASE
ANTI-AGING RESEARCH TO BE COMMERCIALIZED
BioVerity Inc. is pleased to announce an exclusive collaborative research and license agreement with McMaster University in Hamilton, ON, to commercialize a complex dietary supplement aimed to ameliorate processes associated with aging. The formulation was developed by three McMaster University scientists – Dr. David Rollo, Dr. Douglas Boreham and Dr. Jennifer Lemon.
“I kept on hearing about McMaster’s research on aging in the media,” said Max Carbone, CEO of Bioverity. “After a segment on the national news in 2012(1) I talked to my father, a pioneering wellness physician, to ask him what he thought. He agreed with what he heard and encouraged me to speak with the researchers. A year later with key partners Bioverity was founded.”
For over a decade, the McMaster team has worked on optimizing a formulation of food-based ingredients that synergistically address five key aspects associated with aging: oxidative stress, insulin resistance, mitochondrial activity, inflammation, and cellular membrane integrity. Results from research with mice and insects obtained remarkable results. Both insects and mice given the formula had significantly increased longevity (27% in a mouse model of accelerated aging(2)) and mice also maintained youthful levels of learning(3), physical activity and appearance into advanced old age(4). In fact, increases in mouse “healthspan” meant that animals remained youthful for a greater proportion of their lives.
“The formulation has years of science behind it,” said Joe Castaldi, VP Bioverity. “We plan on working with the McMaster team to pursue the full potential of the formula.”
This license agreement enables BioVerity Inc. to quickly move forward with the global commercialization of the complex dietary formula under the brand name BioVerity. Although the formulation consists of compounds known and tested to be safe for human consumption, the company is in the process of raising capital to complete human clinical trials to further validate these health claims in the coming months. Bioverity has been in discussions with several groups to establish an initial U.S. test market, with a subsequent rollout in both Canada and the United States.
BioVerity Inc. was established in 2013 to commercialize McMaster’s evidence-based scientific learning and intellectual property on complex dietary supplements. The company is based in Toronto and is led by: Max Carbone, CEO, Joseph Castaldi, VP, and Dr. Nicholas Rupcich, Chief Science Officer.
To contact BioVerity Inc. please call 1-800-382-1959.
(1) CBC News. Aging slowed in mice with supplement mix. 2 January 2012.
(2) Lyn J, Aksenov V, LeBlanc Z, and Rollo CD.* 2012. Life history features and aging rates: Insights from intra-specific patterns in the cricket Acheta domesticus. Evol. Biol. 39: 371-387. (IF: 3.61)
(3) Aksenov V, Khanna P, Long J, Liu J, Szechtman H, Matravadia S, Rollo CD.* 2012. A complex dietary supplement improves spatial learning, increases brain size and improves mitochondrial activity in aging mice. AGE: DOI: 10.1007/s11357-011-9325-2 (Impact Factor (IF): 6.28.
(4) Lemon, J.A., Boreham, D.R., Rollo, C.D. 2003. A dietary supplement abolishes age-related cognitive decline in transgenic mice expressing elevated free radical processes. Exp. Biol. Med. 228:800-810.